Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator

Aims Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes ventricular arrhythmias (VAs) and sudden cardiac death (SCD). In 2019, a risk prediction model that estimates the 5-year risk of incident VAs in ARVC was developed (ARVCrisk.com). This study aimed to externally validate this predicti...

Full description

Bibliographic Details
Authors: Jorda, P; Bosman, LP; Gasperetti, A; Mazzanti, A; Gourraud, JB; Davies, B; Frederiksen, TC; Weidmann, ZM; Di Marco, A; Roberts, JD; MacIntyre, C; Seifer, C; Deliniere, A; Alqarawi, W; Kukavica, D; Minois, D; Trancuccio, A; Arnaud, M; Targetti, M; Martino, A; Oliviero, G; Pipilas, DC; Carbucicchio, C; Compagnucci, P; Dello Russo, A; Olivotto, I; Calo, L; Lubitz, SA; Cutler, MJ; Chevalier, P; Arbelo, E; Priori, SG; Healey, JS; Calkins, H; Casella, M; Jensen, HK; Tondo, C; Tadros, R; James, CA; Krahn, AD; Cadrin-Tourigny, J
Format: Article
Status:Published version
Publication date:2022
Country:España
Institution:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repository:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p12005
Online Access:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12005
https://ddd.uab.cat/record/282315
Access Level:Open access
Keyword:Arrhythmogenic right ventricular cardiomyopathy
Implantable cardioverter-defibrillator
Sudden cardiac death
Ventricular arrhythmias
Risk stratification
Genetic cardiomyopathies
_version_ 1878740741235146752
author Jorda, P
author2 Bosman, LP
Gasperetti, A
Mazzanti, A
Gourraud, JB
Davies, B
Frederiksen, TC
Weidmann, ZM
Di Marco, A
Roberts, JD
MacIntyre, C
Seifer, C
Deliniere, A
Alqarawi, W
Kukavica, D
Minois, D
Trancuccio, A
Arnaud, M
Targetti, M
Martino, A
Oliviero, G
Pipilas, DC
Carbucicchio, C
Compagnucci, P
Dello Russo, A
Olivotto, I
Calo, L
Lubitz, SA
Cutler, MJ
Chevalier, P
Arbelo, E
Priori, SG
Healey, JS
Calkins, H
Casella, M
Jensen, HK
Tondo, C
Tadros, R
James, CA
Krahn, AD
Cadrin-Tourigny, J
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_browse Alqarawi, W
Arbelo, E
Arnaud, M
Bosman, LP
Cadrin-Tourigny, J
Calkins, H
Calo, L
Carbucicchio, C
Casella, M
Chevalier, P
Compagnucci, P
Cutler, MJ
Davies, B
Deliniere, A
Dello Russo, A
Di Marco, A
Frederiksen, TC
Gasperetti, A
Gourraud, JB
Healey, JS
James, CA
Jensen, HK
Jorda, P
Krahn, AD
Kukavica, D
Lubitz, SA
MacIntyre, C
Martino, A
Mazzanti, A
Minois, D
Oliviero, G
Olivotto, I
Pipilas, DC
Priori, SG
Roberts, JD
Seifer, C
Tadros, R
Targetti, M
Tondo, C
Trancuccio, A
Weidmann, ZM
author_facet Jorda, P
Bosman, LP
Gasperetti, A
Mazzanti, A
Gourraud, JB
Davies, B
Frederiksen, TC
Weidmann, ZM
Di Marco, A
Roberts, JD
MacIntyre, C
Seifer, C
Deliniere, A
Alqarawi, W
Kukavica, D
Minois, D
Trancuccio, A
Arnaud, M
Targetti, M
Martino, A
Oliviero, G
Pipilas, DC
Carbucicchio, C
Compagnucci, P
Dello Russo, A
Olivotto, I
Calo, L
Lubitz, SA
Cutler, MJ
Chevalier, P
Arbelo, E
Priori, SG
Healey, JS
Calkins, H
Casella, M
Jensen, HK
Tondo, C
Tadros, R
James, CA
Krahn, AD
Cadrin-Tourigny, J
author_role author
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
description Aims Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes ventricular arrhythmias (VAs) and sudden cardiac death (SCD). In 2019, a risk prediction model that estimates the 5-year risk of incident VAs in ARVC was developed (ARVCrisk.com). This study aimed to externally validate this prediction model in a large international multicentre cohort and to compare its performance with the risk factor approach recommended for implantable cardioverter-defibrillator (ICD) use by published guidelines and expert consensus. Methods and results In a retrospective cohort of 429 individuals from 29 centres in North America and Europe, 103 (24%) experienced sustained VA during a median follow-up of 5.02 (2.05-7.90) years following diagnosis of ARVC. External validation yielded good discrimination [C-index of 0.70 (95% confidence interval-CI 0.65-0.75)] and calibration slope of 1.01 (95% CI 0.99-1.03). Compared with the three published consensus-based decision algorithms for ICD use in ARVC (Heart Rhythm Society consensus on arrhythmogenic cardiomyopathy, International Task Force consensus statement on the treatment of ARVC, and American Heart Association guidelines for VA and SCD), the risk calculator performed better with a superior net clinical benefit below risk threshold of 35%. Conclusion Using a large independent cohort of patients, this study shows that the ARVC risk model provides good prognostic information and outperforms other published decision algorithms for ICD use. These findings support the use of the model to facilitate shared decision making regarding ICD implantation in the primary prevention of SCD in ARVC.
eu_rights_str_mv openAccess
format article
id ES_d88f374b258df03f21c4fcbad8f9f8a9
institution Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p12005
publishDate 2022
publishDateSort 2022
publisher OXFORD UNIV PRESS
publisherStr OXFORD UNIV PRESS
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
spelling Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator Jorda, P Bosman, LP Gasperetti, A Mazzanti, A Gourraud, JB Davies, B Frederiksen, TC Weidmann, ZM Di Marco, A Roberts, JD MacIntyre, C Seifer, C Deliniere, A Alqarawi, W Kukavica, D Minois, D Trancuccio, A Arnaud, M Targetti, M Martino, A Oliviero, G Pipilas, DC Carbucicchio, C Compagnucci, P Dello Russo, A Olivotto, I Calo, L Lubitz, SA Cutler, MJ Chevalier, P Arbelo, E Priori, SG Healey, JS Calkins, H Casella, M Jensen, HK Tondo, C Tadros, R James, CA Krahn, AD Cadrin-Tourigny, J Arrhythmogenic right ventricular cardiomyopathy Implantable cardioverter-defibrillator Sudden cardiac death Ventricular arrhythmias Risk stratification Genetic cardiomyopathies Aims Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes ventricular arrhythmias (VAs) and sudden cardiac death (SCD). In 2019, a risk prediction model that estimates the 5-year risk of incident VAs in ARVC was developed (ARVCrisk.com). This study aimed to externally validate this prediction model in a large international multicentre cohort and to compare its performance with the risk factor approach recommended for implantable cardioverter-defibrillator (ICD) use by published guidelines and expert consensus. Methods and results In a retrospective cohort of 429 individuals from 29 centres in North America and Europe, 103 (24%) experienced sustained VA during a median follow-up of 5.02 (2.05-7.90) years following diagnosis of ARVC. External validation yielded good discrimination [C-index of 0.70 (95% confidence interval-CI 0.65-0.75)] and calibration slope of 1.01 (95% CI 0.99-1.03). Compared with the three published consensus-based decision algorithms for ICD use in ARVC (Heart Rhythm Society consensus on arrhythmogenic cardiomyopathy, International Task Force consensus statement on the treatment of ARVC, and American Heart Association guidelines for VA and SCD), the risk calculator performed better with a superior net clinical benefit below risk threshold of 35%. Conclusion Using a large independent cohort of patients, this study shows that the ARVC risk model provides good prognostic information and outperforms other published decision algorithms for ICD use. These findings support the use of the model to facilitate shared decision making regarding ICD implantation in the primary prevention of SCD in ARVC. OXFORD UNIV PRESS https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12005 https://ddd.uab.cat/record/282315
spellingShingle Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
Jorda, P
Arrhythmogenic right ventricular cardiomyopathy
Implantable cardioverter-defibrillator
Sudden cardiac death
Ventricular arrhythmias
Risk stratification
Genetic cardiomyopathies
status_str publishedVersion
title Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
title_full Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
title_fullStr Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
title_full_unstemmed Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
title_short Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
title_sort Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
topic Arrhythmogenic right ventricular cardiomyopathy
Implantable cardioverter-defibrillator
Sudden cardiac death
Ventricular arrhythmias
Risk stratification
Genetic cardiomyopathies
topic_facet Arrhythmogenic right ventricular cardiomyopathy
Implantable cardioverter-defibrillator
Sudden cardiac death
Ventricular arrhythmias
Risk stratification
Genetic cardiomyopathies
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12005
https://ddd.uab.cat/record/282315